LH logo

LH

Profile

Full Name

Labcorp Holdings Inc.

Ticker Symbol

LH

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

March 29, 1990

Indexes

S&P 500

Website

http://www.labcorp.com

Employees

60900

Key Details

Price

$235.87

Market Cap

Last Dividend

$0.72

TTM Dividend Yield

1.22%

Annual Revenue

$13.01B(+6.97% YoY)

Annual EPS

$8.84(+85.32% YoY)

PE Ratio

26.74

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$235.87
LH price is $235.87

Price All-time High

$269.94
LH price is currently -12.62% below its historical high of $269.94

Price Today Change

+1.55%
LH price is up +1.55% today

Price YTD Change

+3.27%
LH price is up +3.27% since January 1st

Price 1-year Change

+11.13%
LH price is up +11.13% year-on-year

Price 3-year Change

+4.33%
LH price is up +4.33% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$19.74B
LH market capitalization is $19.74 billion

Market Cap 3-year Change

-6.01%
LH market capitalization is down -6.01% over the past 3 years

Market Cap All-time High

$25.76B
LH market capitalization is currently -23.37% below its historical high of $25.76 billion

Market Cap Sector Rank

95.65%
LH market capitalization is higher than 95.65% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.71%
LH shares outstanding is down -0.71% year-on-year

Shares Outstanding 3-Year Change

-9.9%
LH shares outstanding is down -9.9% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
LH beta is 0.43

200-day SMA

$229.13
LH price is currently +2.94% above its 200-day simple moving average

50-day SMA

$244.26
LH price is currently -3.44% below its 50-day simple moving average

RSI

45.41
LH 14-day relative strength index is 45.41

Volume

1.32
LH 30-day relative volume is 1.32

ATR

$5.09
LH average true range is $5.09

10-day Historical Volatility

16.53%
LH 10-day historical volatility is 16.53%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.72
LH last dividend was $0.72 per share, with an ex-dividend date of February 27, 2025

Next Dividend

-
LH next dividend has not yet been announced

Dividend per share

Dividend Per Share

$2.88
LH annual dividend per share is $2.88

Dividend per share Sector Rank

81.4%
LH annual dividend per share is higher than 81.4% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
LH {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

+260%
LH annual dividend per share is up +260% over the past 3 years

Dividend yield

Dividend Yield

1.22%
LH annual dividend yield is 1.22%

Dividend yield Sector Rank

34.12%
LH annual dividend yield is higher than 34.12% of companies in Healthcare sector

Other

Payout Ratio

32.59%
LH annual payout ratio is 32.59%

Dividends Paid

$243.10M
LH annual dividends paid is $243.10 million

Free Cash Flow

$1.10B
LH annual free cash flow is $1.10 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$13.01B
LH annual revenue is $13.01 billion

Revenue Analysts Estimate

$13.93B
LH annual revenue is currently -6.58% lower than the consensus analysts' forecast

Revenue 1-year Change

+6.97%
LH annual revenue is up +6.97% year-on-year

Revenue Sector Rank

95.37%
LH annual revenue is higher than 95.37% of companies in Healthcare sector

EPS

EPS

$8.84
LH annual earnings per share is $8.84

EPS Analysts Estimate

$16.03
LH annual earnings per share is currently -44.87% lower than the consensus analysts' forecast

EPS 1-year Change

+85.32%
LH annual earnings per share is up +85.32% year-on-year

EPS Sector Rank

97.71%
LH annual earnings per share is higher than 97.71% of companies in Healthcare sector

Profit

Gross Profit

$3.62B
LH annual gross profit is $3.62 billion

Gross Margin

27.86%
LH annual gross profit margin is 27.86%

Operating Profit

$1.14B
LH annual operating income is $1.14 billion

Operating Margin

8.75%
LH annual operating profit margin is 8.75%

Net Income

$746.00M
LH annual net profit is $746.00 million

Net Margin

5.73%
LH annual net profit margin is 5.73%

Expenses

Total Expenses

$11.87B
LH annual total expenses is $11.87 billion

Operating Expenses

$2.49B
LH annual total operating expenses is $2.49 billion

Cost Of Goods Sold

$9.38B
LH annual cost of goods sold is $9.38 billion

Selling, General & Administrative Expenses

$2.23B
LH annual SGA is $2.23 billion

Depreciation And Amortization

$643.50M
LH annual depreciation & amortization is $643.50 million

Interest Expense

$208.30M
LH annual interest expense is $208.30 million

Income Tax

$212.40M
LH annual income tax is $212.40 million

EBIT & EBITDA

EBIT

$1.17B
LH annual earnings before interest & taxes is $1.17 billion

EBITDA

$1.81B
LH annual EBITDA is $1.81 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$18.38B
LH annual total assets is $18.38 billion

Non Current Assets

$13.57B
LH annual long term assets is $13.57 billion

Current Assets

$4.81B
LH annual total current assets is $4.81 billion

Cash And Cash Equivalents

$1.52B
LH annual cash & cash equivalents is $1.52 billion

Accounts Receivable

$1.94B
LH annual accounts receivable is $1.94 billion

Inventory

$493.20M
LH annual inventory is $493.20 million

Liabilities

Total Liabilities

$10.31B
LH annual total liabilities is $10.31 billion

Long Term Liabilities

$6.98B
LH annual total long term liabilities is $6.98 billion

Current Liabilities

$3.33B
LH annual total current liabilities is $3.33 billion

Accounts Payable

$875.80M
LH annual accounts payable is $875.80 million

Debt

Total Debt

$7.27B
LH annual total debt is $7.27 billion

Total Debt 1-year Change

+22.15%
LH annual total debt is up +22.15% year-on-year

Long Term Debt

$6.08B
LH annual long term debt is $6.08 billion

Short Term Debt

$1.19B
LH annual short term debt is $1.19 billion

Equity & Capital

Shareholders Equity

$8.05B
LH annual stockholders equity is $8.05 billion

Book Value

$8.05B
LH annual book value is $8.05 billion

Retained Earnings

$8.30B
LH annual retained earnings is $8.30 billion

Working Capital

$1.48B
LH annual working capital is $1.48 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$1.59B
LH annual cash flow from operations is $1.59 billion

Cash From Operations 1-year Change

+19.44%
LH annual cash flow from operations is up +19.44% year-on-year

Cash From Investing

-$1.37B
LH annual cash flow from investing activities is -$1.37 billion

Cash From Investing 1-year Change

-16.67%
LH annual cash flow from investing activities is down -16.67% year-on-year

Cash From Financing

$779.90M
LH annual cash flow from financing activities is $779.90 million

Cash From Financing 1-year Change

+1415.18%
LH annual cash flow from financing activities is up +1415.18% year-on-year

CAPEX

CAPEX

$489.90M
LH annual capital expenditures is $489.90 million

CAPEX 1-year Change

+8%
LH annual capital expenditures is up +8% year-on-year

Free Cash Flow

Free Cash Flow

$1.10B
LH annual free cash flow is $1.10 billion

Free Cash Flow 1-year Change

+25.37%
LH annual free cash flow is up +25.37% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

27.86%
LH annual gross profit margin is 27.86%

Operating Margin

8.75%
LH annual operating profit margin is 8.75%

Net Margin

5.73%
LH annual net profit margin is 5.73%

ROA & ROE

ROA

4.25%
LH annual return on assets is 4.25%

ROE

9.35%
LH annual return on equity is 9.35%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

26.74
LH price to earnings ratio is 26.74

PE Ratio Sector Rank

53.88%
LH price to earnings ratio is higher than 53.88% of companies in Healthcare sector

PB Ratio

PB Ratio

2.45
LH price to book ratio is 2.45

PB Ratio Sector Rank

67.73%
LH price to book ratio is higher than 67.73% of companies in Healthcare sector

PS Ratio

PS Ratio

1.52
LH price to sales ratio is 1.52

PS Ratio Sector Rank

35.72%
LH price to sales ratio is higher than 35.72% of companies in Healthcare sector

Enterprise value

Enterprise Value

$25.50B
LH enterprise value is $25.50 billion

Enterprise Value Sector Rank

95.7%
LH enterprise value is higher than 95.7% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.08
LH EV/EBITDA is 14.08

EV/EBITDA Sector Rank

86.49%
LH EV/EBITDA is higher than 86.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

1.44
LH annual current ratio is 1.44

Quick Ratio

1.30
LH annual quick ratio is 1.30

Leverage

Debt To Equity

0.79
LH annual debt to equity ratio is 0.79

Interest Coverage Ratio

5.61
LH annual interest coverage ratio is 5.61

Risk & Stability

Piotroski F-Score

7
LH piotroski f-score is 7

Altman Z-Score

2.80
LH altman z-score is 2.80

Analyst ratings

Recent major analysts updates

Mar 4, 25 Citigroup
Buy
Feb 10, 25 Piper Sandler
Neutral
Feb 7, 25 Barclays
Equal-Weight
Feb 6, 25 Jefferies
Buy
Feb 3, 25 Barclays
Equal-Weight
Jan 28, 25 UBS
Buy
Jan 7, 25 Evercore ISI Group
Outperform
Dec 17, 24 Morgan Stanley
Overweight
Dec 13, 24 B of A Securities
Buy
Dec 10, 24 Jefferies
Buy

Institutional Ownership

Similar stocks

MOH logo
Molina Healthcare (MOH)
BIIB logo
Biogen (BIIB)
WAT logo
Waters (WAT)
NTRA logo
Natera (NTRA)
DGX logo
Quest Diagnostics Incorporated (DGX)
PODD logo
Insulet (PODD)
STE logo
STERIS (STE)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
BNTX logo
BioNTech SE (BNTX)
  • What is the ticker symbol for Laboratory Corporation of America Holdings?
  • Does Laboratory Corporation of America Holdings pay dividends?
  • What sector is Laboratory Corporation of America Holdings in?
  • What industry is Laboratory Corporation of America Holdings in?
  • What country is Laboratory Corporation of America Holdings based in?
  • When did Laboratory Corporation of America Holdings go public?
  • Is Laboratory Corporation of America Holdings in the S&P 500?
  • Is Laboratory Corporation of America Holdings in the NASDAQ 100?
  • Is Laboratory Corporation of America Holdings in the Dow Jones?
  • When was Laboratory Corporation of America Holdings's last earnings report?
  • When does Laboratory Corporation of America Holdings report earnings?
  • Should I buy Laboratory Corporation of America Holdings stock now?

What is the ticker symbol for Laboratory Corporation of America Holdings?

The ticker symbol for Laboratory Corporation of America Holdings is NYSE:LH

Does Laboratory Corporation of America Holdings pay dividends?

Yes, Laboratory Corporation of America Holdings pays dividends. The last payment was $0.72, with an ex-dividend date on February 27, 2025

What sector is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Healthcare sector

What industry is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Diagnostics & Research industry

What country is Laboratory Corporation of America Holdings based in?

Laboratory Corporation of America Holdings is headquartered in United States

When did Laboratory Corporation of America Holdings go public?

Laboratory Corporation of America Holdings's initial public offering (IPO) was on March 29, 1990

Is Laboratory Corporation of America Holdings in the S&P 500?

Yes, Laboratory Corporation of America Holdings is included in the S&P 500 index

Is Laboratory Corporation of America Holdings in the NASDAQ 100?

No, Laboratory Corporation of America Holdings is not included in the NASDAQ 100 index

Is Laboratory Corporation of America Holdings in the Dow Jones?

No, Laboratory Corporation of America Holdings is not included in the Dow Jones index

When was Laboratory Corporation of America Holdings's last earnings report?

Laboratory Corporation of America Holdings's most recent earnings report was on Feb 6, 2025

When does Laboratory Corporation of America Holdings report earnings?

The next expected earnings date for Laboratory Corporation of America Holdings is Apr 25, 2025

Should I buy Laboratory Corporation of America Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page